Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
Leonardi A., Messmer E.M., Labetoulle M., Amrane M., Garrigue J.-S., Ismail D., Sainz-De-La-Maza M., Figueiredo F.C., Baudouin C.
View publication
-
Therapeutic Area
Front of the eye (FOTE)
-
Technology
Other
-
Categories
Clinical development
-
Affiliations
Department of Neuroscience, Ophthalmology Unit, University of Padua, Giustiniani 2, Padua, 35128, Italy; Department of Ophthalmology, Ludwig-Maximilian University of Munich, Munich, Germany; Department of Ophthalmology, Bicêtre Hospital, APHP, Paris-Sud University, Le Kremlin Bicêtre, France; Santen SAS, Evry, France; Institute Clinic of Ophthalmology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Department of Ophthalmology, Royal Victoria Infirmary, Newcastle University, Newcastle Upon Tyne, United Kingdom; Quinze-Vingts National Ophthalmology Hospital, Paris, France; Vision Institute, INSERM UMRS968, CNRS UMR7210, UPMC University, Paris, France; University of Versailles Saint-Quentin en Yvelines, Versailles, France